Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
27 août 2024 08h00 HE
|
Predictive Oncology Inc.
Study further validates highly reproducible drug response data. Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen market valued at $4.4 billion in...
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 07h00 HE
|
Predictive Oncology Inc.
PITTSBURGH, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
13 août 2024 07h00 HE
|
Predictive Oncology Inc.
Findings demonstrate real-world applications of Company’s AI platform to support biomarker discovery, clinical trial optimization and target validation Proprietary tool accounts for patient...
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
07 août 2024 07h00 HE
|
Predictive Oncology Inc.
PITTSBURGH, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
26 juil. 2024 08h00 HE
|
Predictive Oncology Inc.
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that it has entered into a definitive...
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
25 juil. 2024 07h00 HE
|
Predictive Oncology Inc.
Expands AI/ML driven offering to include novel oncology biomarker discovery to predict patient outcomes and drug response in oncology Biomarker discovery market estimated by third party research to...
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
11 juin 2024 08h00 HE
|
Predictive Oncology Inc.
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value...
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
04 juin 2024 08h42 HE
|
Predictive Oncology Inc.
Predictive Oncology’s organ-specific in vitro models are designed to better mimic the physiological environment of human tissue The 3D cell culture market is projected to grow by more than 14%...
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
29 mai 2024 07h00 HE
|
Predictive Oncology Inc.
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond Vennare, Chief Executive...
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
28 mai 2024 07h00 HE
|
Predictive Oncology Inc.
PITTSBURGH, May 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that positive results from a retrospective...